A detailed history of Capital Performance Advisors LLP transactions in Medtronic PLC stock. As of the latest transaction made, Capital Performance Advisors LLP holds 6,433 shares of MDT stock, worth $605,538. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,433
Previous 5,261 22.28%
Holding current value
$605,538
Previous $458,000 33.62%
% of portfolio
0.1%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$87.67 - $95.74 $102,749 - $112,207
1,172 Added 22.28%
6,433 $612,000
Q2 2025

Aug 04, 2025

SELL
$80.68 - $88.86 $100,688 - $110,897
-1,248 Reduced 19.17%
5,261 $458,000
Q1 2025

May 09, 2025

BUY
$79.84 - $94.5 $149,380 - $176,809
1,871 Added 40.34%
6,509 $584,000
Q4 2024

Jan 31, 2025

BUY
$79.61 - $92.24 $149,746 - $173,503
1,881 Added 68.23%
4,638 $370,000
Q3 2024

Nov 01, 2024

BUY
$76.84 - $91.03 $211,847 - $250,969
2,757 New
2,757 $248,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $125B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.